UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

Aptamers: Promising Tools for Cancer Diagnosis and Therapy

Cancers, 2018-05, Vol.10 (5), p.132

Cerchia, Laura

2018

Link zum Volltext

Verfügbarkeit prüfen

Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma

International journal of molecular sciences, 2019-06, Vol.20 (11), p.2746

2019

Link zum Volltext

Verfügbarkeit prüfen

The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression

International journal of molecular sciences, 2022-01, Vol.23 (2), p.800

2022

Link zum Volltext

Verfügbarkeit prüfen

The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas

Cancers, 2017-09, Vol.9 (10), p.134

2017

Link zum Volltext

Verfügbarkeit prüfen

TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities

Pharmaceuticals (Basel, Switzerland), 2018-11, Vol.11 (4), p.123

2018

Link zum Volltext

Verfügbarkeit prüfen

The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement

International journal of molecular sciences, 2017-11, Vol.18 (12), p.2524

2017

Link zum Volltext

Verfügbarkeit prüfen

Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy

Molecular therapy, 2014-06, Vol.22 (6), p.1151-1163

2014

Link zum Volltext

Verfügbarkeit prüfen

Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors

Journal of experimental & clinical cancer research, 2021-07, Vol.40 (1), p.239-17, Article 239

2021

Link zum Volltext

Verfügbarkeit prüfen

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof

Pharmaceutics, 2021-12, Vol.14 (1), p.28

2021

Link zum Volltext

Verfügbarkeit prüfen

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

PloS one, 2011-09, Vol.6 (9), p.e24071-e24071

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing

Cancers, 2019-08, Vol.11 (9), p.1268

2019

Link zum Volltext

Verfügbarkeit prüfen

Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression

Cells (Basel, Switzerland), 2024-02, Vol.13 (4), p.350

2024

Link zum Volltext

Verfügbarkeit prüfen

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Journal of experimental & clinical cancer research, 2020-09, Vol.39 (1), p.180-180, Article 180

2020

Link zum Volltext

Verfügbarkeit prüfen

Optimization of Short RNA Aptamers for TNBC Cell Targeting

International journal of molecular sciences, 2022-03, Vol.23 (7), p.3511

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion

Journal of experimental & clinical cancer research, 2022-04, Vol.41 (1), p.122-122, Article 122

2022

Link zum Volltext

Verfügbarkeit prüfen

Aptamer-Based Strategies to Boost Immunotherapy in TNBC

Cancers, 2023-03, Vol.15 (7), p.2010

2023

Link zum Volltext

Verfügbarkeit prüfen

Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells

Cancers, 2020-02, Vol.12 (2), p.331

2020

Link zum Volltext

Verfügbarkeit prüfen

Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies

Journal of experimental & clinical cancer research, 2024-03, Vol.43 (1), p.92-92, Article 92

2024

Link zum Volltext

Verfügbarkeit prüfen

Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles

Pharmaceutics, 2022-03, Vol.14 (3), p.626

2022

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase

PLoS biology, 2005-04, Vol.3 (4), p.e123-e123

2005

Link zum Volltext

Verfügbarkeit prüfen

Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells

Pharmaceutics, 2022-10, Vol.14 (10), p.2225

2022

Link zum Volltext

Verfügbarkeit prüfen

The isolectin IB4 binds RET receptor tyrosine kinase in microglia

Journal of neurochemistry, 2013-08, Vol.126 (4), p.428-436

2013

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition

Endocrines, 2021-10, Vol.2 (4), p.427-438

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells

Cells (Basel, Switzerland), 2023-01, Vol.12 (2), p.298

2023

Link zum Volltext

Verfügbarkeit prüfen

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells

Cells (Basel, Switzerland), 2023-07, Vol.12 (13), p.1809

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(117)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aptamers: Promising Tools for Cancer Diagnosis and Therapy

Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma

The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression

The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas

TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities

The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement

Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy

Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors

Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof

A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death

Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing

Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer

Optimization of Short RNA Aptamers for TNBC Cell Targeting

Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion

Aptamer-Based Strategies to Boost Immunotherapy in TNBC

Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells

Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies

Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles

Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase

Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells

The isolectin IB4 binds RET receptor tyrosine kinase in microglia

Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition

Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells

Suchergebnisse filtern